Indazole compounds useful as protein kinase inhibitors
Details for Australian Patent Application No. 2003212833 (hide)
International Classifications
Event Publications
24 July 2003 Complete Application Filed
Priority application(s): 60/351,597 25.01.02 US
18 September 2003 Application Open to Public Inspection
Published as AU-B-2003212833
21 February 2008 Application Accepted
Published as AU-B-2003212833
19 June 2008 Standard Patent Sealed
19 August 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 15 Jul 2010. Address for service in Australia - Cullens Patent and Trade Mark Attorneys Level 32 239 George Street Brisbane QLD 4000
23 December 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 15 Jul 2010 2003275396 BP Corporation North America Inc. The nature of the amendment is as shown in the statement(s) filed 22 Mar 2010
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003212834-SUBSTANTIALLY FLUSH MOUNTED VEHICULAR WINDOW FRAME ASSEMBLY AND METHOD FOR PRODUCING
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser